Steven Cohen’s PDS Biotechnology PDSB Stock Holding History

Steven Cohen’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,811	Closed	-$48K	–	2628
2023 Q1	$48K	Buy	+7,811	New	+$63.9K	﹤0.01%	1790

Other funds holding PDSB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Steven Cohen's PDSB Position: Q2 2023 in Review

Steven Cohen sold out of PDS Biotechnology (PDSB) in Q2 2023, closing a stake of 7,811 shares — an estimated $48K sold.

Steven Cohen first reported a position in PDSB in Q1 2023 and held it in 1 quarter. The position peaked at $48K in Q1 2023. 80 funds tracked by Wall St. Rank hold PDSB as of Q2 2023.

Steven Cohen reported no remaining PDS Biotechnology position as of Q2 2023 after selling out during the quarter.
Steven Cohen sold 7,811 PDS Biotechnology shares in Q2 2023, an estimated $48K.
Steven Cohen first reported a position in PDS Biotechnology in Q1 2023 and held it in 1 quarter.
Steven Cohen's PDS Biotechnology position peaked at $48K in Q1 2023.
80 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.